DK1027895T3 - Erysipelothrix rhusiopathiae-antigener og vaccinepræparater - Google Patents

Erysipelothrix rhusiopathiae-antigener og vaccinepræparater

Info

Publication number
DK1027895T3
DK1027895T3 DK99309202T DK99309202T DK1027895T3 DK 1027895 T3 DK1027895 T3 DK 1027895T3 DK 99309202 T DK99309202 T DK 99309202T DK 99309202 T DK99309202 T DK 99309202T DK 1027895 T3 DK1027895 T3 DK 1027895T3
Authority
DK
Denmark
Prior art keywords
vaccine preparations
erysipelothrix rhusiopathiae
antigens
rhusiopathiae antigens
erysipelothrix
Prior art date
Application number
DK99309202T
Other languages
English (en)
Inventor
David Stewart Roberts
Brian Thomas Suiter
Leroy Allen Swearingin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1027895T3 publication Critical patent/DK1027895T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK99309202T 1999-01-29 1999-11-18 Erysipelothrix rhusiopathiae-antigener og vaccinepræparater DK1027895T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11770499P 1999-01-29 1999-01-29

Publications (1)

Publication Number Publication Date
DK1027895T3 true DK1027895T3 (da) 2008-06-09

Family

ID=22374369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99309202T DK1027895T3 (da) 1999-01-29 1999-11-18 Erysipelothrix rhusiopathiae-antigener og vaccinepræparater

Country Status (17)

Country Link
EP (1) EP1027895B1 (da)
JP (3) JP3535436B2 (da)
CN (1) CN1210062C (da)
AR (1) AR020022A1 (da)
AT (1) ATE386540T1 (da)
AU (1) AU776847B2 (da)
BR (1) BR9905853B1 (da)
CA (1) CA2290078C (da)
CY (1) CY1107910T1 (da)
DE (1) DE69938168T2 (da)
DK (1) DK1027895T3 (da)
ES (1) ES2301230T3 (da)
HK (1) HK1029062A1 (da)
NZ (1) NZ501128A (da)
PT (1) PT1027895E (da)
TW (1) TW546146B (da)
ZA (1) ZA997138B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CN107496913A (zh) * 2017-09-15 2017-12-22 天津瑞普生物技术股份有限公司 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法
CN107648599A (zh) * 2017-09-18 2018-02-02 天津瑞普生物技术股份有限公司 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法
CN110812473A (zh) * 2019-12-10 2020-02-21 广东君睿生物技术研究有限公司 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5616328A (en) * 1991-11-15 1997-04-01 Pfizer Inc. Method of preparing gram-negative bacterial vaccines
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
JP3072345B1 (ja) * 1999-03-31 2000-07-31 農林水産省家畜衛生試験場長 豚丹毒菌の組換えサブユニットワクチン

Also Published As

Publication number Publication date
JP2003160507A (ja) 2003-06-03
BR9905853A (pt) 2000-11-14
AU776847B2 (en) 2004-09-23
ATE386540T1 (de) 2008-03-15
ES2301230T3 (es) 2008-06-16
HK1029062A1 (en) 2001-03-23
JP4714167B2 (ja) 2011-06-29
CA2290078A1 (en) 2000-07-29
JP2007119499A (ja) 2007-05-17
PT1027895E (pt) 2008-03-18
JP2000219637A (ja) 2000-08-08
AU5944599A (en) 2000-08-03
NZ501128A (en) 2001-12-21
DE69938168T2 (de) 2009-02-26
ZA997138B (en) 2001-05-16
EP1027895A2 (en) 2000-08-16
EP1027895A3 (en) 2001-07-18
AR020022A1 (es) 2002-03-27
DE69938168D1 (de) 2008-04-03
CN1262129A (zh) 2000-08-09
CY1107910T1 (el) 2013-09-04
CA2290078C (en) 2013-01-22
JP3535436B2 (ja) 2004-06-07
BR9905853B1 (pt) 2011-11-01
EP1027895B1 (en) 2008-02-20
CN1210062C (zh) 2005-07-13
TW546146B (en) 2003-08-11

Similar Documents

Publication Publication Date Title
FR2775601B1 (fr) Vaccins vivants recombines et adjuves
DK1210113T3 (da) Kombinerede vaccinepræparater
CY2009014I1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
DK0894135T3 (da) Multivalent og multispecifikt antigenbindingsprotein
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
EP1309602A4 (en) MALARIA IMMUNOGEN AND VACCINE
NO20003303L (no) Vaksine
DE60031859D1 (de) Genetisch manipulierter bleb impfstoff
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
DK1228217T3 (da) Konserverede neisseria-antigener
BR9711853A (pt) Vacinas
DK1163271T3 (da) Rekombinant IL-18 antistoffer og deres anvendelse
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
DK1309692T3 (da) Anti-IL12-antistoffer, præparater, fremgangsmåder og anvendelser
NO20032303D0 (no) Frysetörket pantoprazol-preparat og pantoprazol-injeksjon
NO2006005I1 (no) Difteri-,tetanus-, acellulære kikhoste- og polioantigener
IS4615A (is) Mótefnavakar Helicobacter pylori og bóluefnablöndur
DK1210112T3 (da) Vaccine mod HBV og HPV
EP1242049A4 (en) HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINES
NO20020763L (no) Vaksine
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
IS6381A (is) Nýjung við notkun mótefna í bóluefni
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
DK1027895T3 (da) Erysipelothrix rhusiopathiae-antigener og vaccinepræparater
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos